Therapeutic Proteins & Peptides

In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information about therapeutic protein & peptide targets, technologies, pipelines and markets. The range of products covers industry data as well as in-depth strategic assessment and analysis of protein technologies, targets, product profiles, companies, R&D pipelines, deals and financing.

Subscribe to
our newsletters!

Showing all 4 results

  • April of 2019
    This report provides an overview of therapeutic proteins in development for treatment of arginine-dependent tumors or for enzyme replacement therapy.
     75.00
  • March of 2019
    This Target Pipeline List provides an overview of biologic and chemical entities on the market or in development for treatment of hyperuricemia associated with gout or tumor lysis
     150.00
  • February of 2019
    This report provides an overview of isolated and recombinant asparaginase enzymes on the market or in development for treatment of leukemia and solid tumors.
     100.00
  • January of 2019
    This Target Pipeline List provides an overview of biologic and small molecule approaches to raise high density lipoprotein (HDL) for reduction of recurrent cardiovascular events.
     100.00